share email twitter ⋅ join discord whatsapp(2ck)
Free 120  NBME 24  NBME 23  NBME 22  NBME 21  NBME 20  NBME 19  NBME 18  NBME 17  NBME 16  NBME 15  NBME 13 
introducing : the “predict me” score predictor NEW!

NBME 21 Answers

nbme21/Block 1/Question#9 (15.0 difficulty score)
A 53-year-old woman who underwent an ...
Breast: antagonist; Uterus: partial agonistπŸ”

Login to comment/vote.

Tutor box

Members from the Leaderboard offering 1-on-1 help: Want to be listed here? Email us!

submitted by pparalpha(84),
unscramble the site ⋅ remove ads ⋅ become a member ($39/month)


icnsa:mhMe esevecilt tsgneroe rcoeetpr troloadmu R)EM(S atth satc sa an nittnagsao on hte regontse spocertre of eth bearts adn tacs as an aiplrta igtaosn on resntego rpecresot ni beno adn u.ruset ehfeor,rTe ↑ kris fo oldnetimera rencca nda ↑ iskR of ietneru samorca

s:seU ER ro RP vteioips urosmt rbe()sat

submitted by baja_blast(113),

Whole point of administering a SERM after breast cancer is to reduce risk of recurrence. Increased estrogen exposure is associated with increased risk of breast cancer (per FA 2019 p. 636). So you're looking for something that is an estrogen antagonist at the breast, which narrows it down to B and C right off the bat.